Neoplasm Recurrence, LocalDisease-Free SurvivalPrognosisRecurrenceSurvival RateNeoplasm StagingBreast NeoplasmsTreatment OutcomeRetrospective StudiesSurvival AnalysisCombined Modality TherapyChemotherapy, AdjuvantFollow-Up StudiesKaplan-Meier EstimateRadiotherapy, AdjuvantLymphatic MetastasisTumor Markers, BiologicalAntineoplastic Combined Chemotherapy ProtocolsReceptors, EstrogenProportional Hazards ModelsImmunohistochemistryNeoplasm MetastasisCarcinoma, Ductal, BreastFluorouracilNeoplasm InvasivenessReceptor, erbB-2Multivariate AnalysisTime FactorsProspective StudiesTamoxifenCell SurvivalAdenocarcinomaRadiotherapy DosageReceptors, ProgesteroneRisk FactorsPredictive Value of TestsRectal NeoplasmsCarcinoma, Squamous CellColorectal NeoplasmsSarcomaAntineoplastic Agents, HormonalLiver NeoplasmsCyclophosphamideCarcinomaNeoadjuvant TherapyLymph Node ExcisionImmunoenzyme TechniquesMastectomyMastectomy, SegmentalLymph NodesRisk AssessmentGene Expression Regulation, NeoplasticSurvivalLung NeoplasmsRandomized Controlled Trials as TopicCisplatinAntineoplastic AgentsNeoplasm GradingGraft SurvivalBone NeoplasmsDisease ProgressionVincristineCohort StudiesCarcinoma, HepatocellularDoxorubicinRemission InductionPostmenopauseChemoradiotherapySalvage TherapyDrug Administration ScheduleOvarian NeoplasmsRadiotherapyCarcinoma, Non-Small-Cell LungEtoposideHead and Neck NeoplasmsBrachytherapyMethotrexateActuarial AnalysisAge FactorsPrednisoneBrain NeoplasmsLymphoma, Non-HodgkinNeoplasm, ResidualOsteosarcomaFree RadicalsCarboplatinHodgkin DiseaseHepatectomyStomach NeoplasmsPancreatic NeoplasmsNeoplasm ProteinsNeoplasms, Germ Cell and EmbryonalTransplantation, AutologousUrinary Bladder NeoplasmsTransplantation, HomologousHematopoietic Stem Cell TransplantationProstatic NeoplasmsTomography, X-Ray ComputedPaclitaxelPostoperative Complications